PGAM4 Activators is a putative class of biochemical compounds postulated to selectively enhance the expression or activity of Phosphoglycerate Mutase 4 (PGAM4), a specialized isozyme implicated in the interconversion of 3-phosphoglycerate and 2-phosphoglycerate during glycolysis and gluconeogenesis. Compounds falling within this class are characterized by their ability to interact with the regulatory mechanisms governing the PGAM4 gene or the enzyme's biochemical activity. The induction of PGAM4 activity may occur through a variety of molecular interactions and pathways, reflecting the diverse nature of these compounds. Some might engage directly with the PGAM4 enzyme, inducing a conformational change that increases its catalytic efficiency. Others could interact with the genetic elements controlling PGAM4 expression, such as promoter regions or transcription factors, to upregulate the production of this enzyme at the transcriptional level. Additionally, molecules in this class may stabilize PGAM4 mRNA, thereby enhancing translation and leading to an increase in enzyme levels.
The scope of molecules encompassed within the PGAM4 Activators class is broad, including small organic molecules, peptides, and potentially other biologically active compounds. Their modes of action are equally varied, with some potentially mimicking the effect of natural cellular activators or cofactors of the PGAM4 enzyme, while others might inhibit negative regulatory elements that suppress PGAM4 expression or activity. The specificity of these compounds towards PGAM4 is a critical aspect of their classification, distinguishing them from broader acting agents that affect multiple targets within metabolic pathways. Their interaction with PGAM4 may influence metabolic flux through glycolytic and gluconeogenic pathways, reflecting the enzyme's role in these central metabolic processes. The diversity of structures within this chemical class is reflective of the complexity of biological regulation, with each compound potentially offering a unique profile of interaction with the enzyme or its regulatory machinery.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May demethylate DNA at the PGAM4 gene promoter, potentially upregulating PGAM4 expression by enhancing transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Could inhibit histone deacetylases, leading to a more open chromatin structure at the PGAM4 locus, increasing gene expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Might activate adenylate cyclase, increasing cAMP levels, and promoting the transcription of cAMP-responsive genes like PGAM4. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
May modulate gene expression through retinoic acid receptors, which could include upregulation of PGAM4. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Could activate Nrf2, which may lead to the upregulation of antioxidant response genes, potentially including PGAM4 if it has antioxidant response elements. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As an HDAC inhibitor, it might increase the expression of various genes, including PGAM4, by altering chromatin structure. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Might influence gene expression patterns through epigenetic modifications, which could lead to upregulation of PGAM4. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Could modulate transcription factor activity, potentially affecting PGAM4 expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Might affect glycogen synthase kinase 3 (GSK-3) activity, influencing Wnt signaling and possibly PGAM4 expression. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
May activate AMPK, leading to changes in cellular metabolism and gene expression, including that of PGAM4. | ||||||